Proinflammatory proteins in female and male patients with primary antiphospholipid syndrome: preliminary data
- PMID: 27370963
- DOI: 10.1007/s10067-016-3345-3
Proinflammatory proteins in female and male patients with primary antiphospholipid syndrome: preliminary data
Abstract
The latest classification criteria for the diagnosis of the antiphospholipid syndrome (APS, an autoimmune disease characterized by thromboses, miscarriages and presence of antiphospholipid antibodies (Abs)) emphasized that thrombotic manifestations of APS should be without any signs of an inflammatory process. However, atherosclerosis (a chronic inflammatory response to the accumulation of lipoproteins in the walls of arteries) and APS are characterized by some similar features. We evaluated whether proinflammatory proteins were associated with the features of the primary APS (PAPS). PAPS patients without obstetric complications and with impaired lipid profile were included in the study. Antiphospholipid antibodies, TNF-alpha, and apo(a) were determined by ELISA. Complement components and hsCRP were measured by immunonephelometry. Decreased C3c was observed in female patients with increased titers of IgG anti-β2gpI (χ(2) = 3.939, P = 0.047) and in male patients with increased IgM anticardiolipin Abs (χ(2) = 4.286, P = 0.038). Pulmonary emboli were associated with interleukin (IL)-6 in male (χ(2) = 6.519, P = 0.011) and in female (χ(2) = 10.405, P = 0.001) patients. Cerebrovascular insults were associated with LDL-cholesterol (P = 0.05, 95 % CI: 1.003 - 12.739) in female and with apo(a) (P = 0.016, 95 % CI: 0.000-0.003) in male patients. Older female patients had increased LDL-cholesterol levels and frequency of myocardial infarctions. Proinflammatory proteins were associated with features of primary APS. No real gender differences in regard to proinflammatory protein levels were observed. Premenopausal state of female PAPS patients confers lower cardiovascular risk.
Keywords: Antiphospholipid syndrome; Complement; High-sensitivity C-reactive protein; Interleukin 6; TNF-alpha.
Similar articles
-
Detrimental roles of TNF-alpha in the antiphospholipid syndrome and de novo synthesis of antiphospholipid antibodies induced by biopharmaceuticals against TNF-alpha.J Thromb Thrombolysis. 2017 Nov;44(4):565-570. doi: 10.1007/s11239-017-1571-4. J Thromb Thrombolysis. 2017. PMID: 29027631 Review.
-
Double positivity of the IgG isotype of both anticardiolipin and anti-β2gpI antibodies is associated with the highest number of vascular impairment parameters in patients with primary antiphospholipid syndrome: preliminary data.Clin Rheumatol. 2016 Dec;35(12):2947-2954. doi: 10.1007/s10067-016-3438-z. Epub 2016 Oct 14. Clin Rheumatol. 2016. PMID: 27743141
-
IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome.Clin Chem Lab Med. 2014 Sep;52(9):1329-33. doi: 10.1515/cclm-2014-0039. Clin Chem Lab Med. 2014. PMID: 24651022
-
Evaluation of the clinical relevance of anti-annexin-A5 antibodies in Chinese patients with antiphospholipid syndrome.Clin Rheumatol. 2017 Feb;36(2):407-412. doi: 10.1007/s10067-016-3510-8. Epub 2016 Dec 21. Clin Rheumatol. 2017. PMID: 28000012
-
[Antiphospholipid syndrome diagnosis: an update].Ann Biol Clin (Paris). 2011 Jul-Aug;69(4):411-8. doi: 10.1684/abc.2011.0592. Ann Biol Clin (Paris). 2011. PMID: 21896405 Review. French.
Cited by
-
Detrimental roles of TNF-alpha in the antiphospholipid syndrome and de novo synthesis of antiphospholipid antibodies induced by biopharmaceuticals against TNF-alpha.J Thromb Thrombolysis. 2017 Nov;44(4):565-570. doi: 10.1007/s11239-017-1571-4. J Thromb Thrombolysis. 2017. PMID: 29027631 Review.
-
Double positivity of the IgG isotype of both anticardiolipin and anti-β2gpI antibodies is associated with the highest number of vascular impairment parameters in patients with primary antiphospholipid syndrome: preliminary data.Clin Rheumatol. 2016 Dec;35(12):2947-2954. doi: 10.1007/s10067-016-3438-z. Epub 2016 Oct 14. Clin Rheumatol. 2016. PMID: 27743141
-
Antiphospholipid antibodies in healthy Serbian middle-aged subjects: Preliminary data.J Med Biochem. 2022 Oct 15;41(4):506-512. doi: 10.5937/jomb0-35642. J Med Biochem. 2022. PMID: 36381077 Free PMC article.
-
Antibodies Against Complement Components: Relevance for the Antiphospholipid Syndrome-Biomarkers of the Disease and Biopharmaceuticals.Curr Rheumatol Rep. 2017 Jul;19(7):40. doi: 10.1007/s11926-017-0669-1. Curr Rheumatol Rep. 2017. PMID: 28631067 Review.
-
Adiponectin: a therapeutic target in the antiphospholipid syndrome?Rheumatol Int. 2019 Sep;39(9):1519-1525. doi: 10.1007/s00296-019-04349-x. Epub 2019 Jun 18. Rheumatol Int. 2019. PMID: 31214769 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous